Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Factors Affecting Erythropoiesis

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...

Disorders of Erythrocytes

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

Erythropoiesis

Erythropoiesis

Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...

Peritoneal Dialysis III: Nursing Management

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...

Factors Affecting Respiration

Factors Affecting Respiration

Respiration is a crucial physiological function involving exchanging oxygen (O2) and carbon dioxide (CO2) between an organism and its environment. Various factors can impact this essential process:

Overview of Hematopoiesis

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Towards a Vision for HEOR: From Technology Appraisal to Health Policy Science.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Same author

The cost of non-drug interventions that improve function and reduce dementia-related behaviors.

BMC geriatrics·2025

Same author

Toward a payment model for augmenting Adult Day Services (ADS) with caregiver support: costs, willingness, and ability to pay for the ADS Plus program.

Innovation in aging·2025

Same author

Taking Health Economics and Outcomes Research Forward: Expanding the Definition of Value to Include Whole Health.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2025

Same author

Patient Navigators Improve In-Office Eye Exam Adherence After Community Eye Screenings in a Randomized Clinical Trial: NYC-SIGHT Study.

American journal of ophthalmology·2025

Same author

The Value of the Quality-Adjusted Life Years.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2024

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Economic considerations in a changing anemia environment.

Laura T Pizzi¹

¹Department of Health Policy, Jefferson Medical College, Philadelphia, PA, USA. laura.pizzi@jefferson.edu

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation

|November 26, 2008

Summary

This summary is machine-generated.

Managing anemia in chronic kidney disease requires cost-effective strategies. Intravenous iron may reduce erythropoiesis-stimulating agent (ESA) needs, improving efficiency in bundled payment models.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Related Experiment Videos

Last Updated: Jun 28, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Area of Science:

Nephrology
Pharmacoeconomics

Background:

Anemia management in chronic kidney disease (CKD) faces challenges due to erythropoiesis-stimulating agent (ESA) safety and cost.
Current Medicare reimbursement policies for ESAs may not incentivize efficient use.
Upcoming bundled payment systems necessitate cost-effective treatment strategies for CKD anemia.

Purpose of the Study:

To evaluate the cost-saving potential of intravenous (IV) iron by assessing its erythropoiesis-stimulating agent (ESA)-sparing effects.
To analyze data from the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) studies.

Main Methods:

Analysis of the DRIVE studies.
Comparison of ESA requirements in patients receiving IV iron versus ESA alone.
Focus on patients with elevated serum ferritin and low transferrin saturation.

Main Results:

A 1-g course of IV iron (sodium ferric gluconate) decreased ESA requirements in ESA-treated patients with high ferritin and low transferrin saturation.
This effect was observed compared to administering an ESA alone.

Conclusions:

IV iron administration in specific CKD patient populations (high ferritin, low transferrin saturation) can reduce ESA needs.
This approach offers a potential strategy for enhancing treatment efficiency within bundled reimbursement frameworks.